삼성서울병원

Ko En

Hematology-Oncology Jang, Jun Ho M.D

Expertise
Aplastic anemia, ITP, myelodysplastic syndrome, acute leukemia, MPN
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM
Treament Schedule 07 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
WEB
31
AM
PM

Medical Education

2000~2002 Ph.D. in Medicine Graduate School, Yonsei University, Korea
1998~2000 Master of Science Graduate School, Yonsei University, Korea
1986~1992 College of Medicine, Yonsei University, Korea

Post-Graduate Training

Fellowship   2002~2004 University of Michigan Ann Arbor, USA
2000~2002 Hematology-Oncology, Severance Hospital, College of Medicine Yonsei University, Korea
Residency   1999~2002 Internal Medicine, Severance Hospital, College of Medicine Yonsei University, Korea
Internship   1995~1996 Severance Hospital, College of Medicine Yonsei University, Korea

Professional Appointments

2014~present Professor Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center
2013~2015 Chief Division of Hematology-Oncology, Samsung Medical Center
2007~2013 Associate Professor Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center
2004~2007 Clinical Instructor Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea

Professional Memberships

2022~Present Director The Korean Society of blood transfusion
2019~Present Chairman of the commission The Korean Society of Hematology aplastic anemia working Party
2014~Present Director The Korean Society for patient blood management
2010~Present Member The Korean Association of internal medicine
2007~Present Member The Korean Society of Blood and marrow transplantation
1998~Present Member The Korean Society of Hematology
2000~Present Member The American Society of Hematology
2000~Present Member The European Hematology Association

Selected Publications

  • ASIA-PAC J CLIN ONCO 2021 10.1111/ajco.13609 Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia Kobayashi1, Y; Oh, I; Miyamoto, T; Lee, WS; Iida, H; Minami, H; Maeda, Y; Jang, JH; Yoon, SS; Yeh, SP; Tran, Q; Morris, J; Franklin, J; Kiyoi, H
    View PubMed
  • ANN LAB MED 2021 10.3343/alm.2021.41.3.342 LSAMP Rearrangement in Acute Myeloid Leukemia With a Jumping Translocation Involving 3q13.31 Yoon1, J; Cho, EH; Yun, JW; Kim, HY; Jang, JH; Kim, HJ; Kim, SH
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.385 Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome Jung1, HA; Jung, CW; Jang, JH
    View PubMed
  • J CLIN ONCOL 2021 10.1200/JCO.20.01895 Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Steensma1, DP; Fenaux, P; Van Eygen, K; Raza, A; Santini, V; Germing, U; Font, P; Diez-Campelo, M; Thepot, S; Vellenga, E; Patnaik, MM; Jang, JH; Varsos, H; Bussolari, J; Rose, E; Sherman, L; Sun, LB; Wan, Y; Dougherty, S; Huang, F; Feller, F; Rizo, A; Platzbecker, U
    View PubMed
  • BRIT J HAEMATOL 2021 10.1111/bjh.17190 Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study Jang1, JH; Tomiyama, Y; Miyazaki, K; Nagafuji, K; Usuki, K; Uoshima, N; Fujisaki, T; Kosugi, H; Matsumura, I; Sasaki, K; Kizaki, M; Sawa, M; Hidaka, M; Kobayashi, N; Ichikawa, S; Yonemura, Y; Enokitani, K; Matsuda, A; Ozawa, K; Mitani, K; Lee, JW; Nakao, S
    View PubMed